The results of the cancer-related pathway analysis showed that the high expression of these antigen genes was mainly related to the activation of the epithelial–mesenchymal transition (EMT) pathway, whereby CR1 and SEMA7A were involved in up to 41% of cancer types (Supplementary Figure S2). The gene discussed is CR1; the disease is cancer.